Prothelia Revenue and Competitors
Estimated Revenue & Valuation
- Prothelia's estimated annual revenue is currently $1.1M per year.
- Prothelia's estimated revenue per employee is $155,000
Employee Data
- Prothelia has 7 Employees.
- Prothelia grew their employee count by -61% last year.
Prothelia's People
Name | Title | Email/Phone |
---|
Prothelia Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Prothelia?
Prothelia is developing recombinant human Laminin-111 (rhLAM-111) for treatment of congenital muscular dystrophy type 1A. This form of muscular dystrophy is also referred to as MDC1A, Merosin deficiency or LAMA2 deficiency.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
-61%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 7 | -22% | N/A |
#2 | $0.1M | 7 | 0% | $25M |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.5M | 7 | N/A | N/A |
#5 | $0.1M | 7 | 0% | $3.1M |